How immune B cells and antibodies in preeclampsia affect blood pressure, thinking, and kidney health in moms and their children

Sex differences in hypertension, cognitive function and renal hemodynamics; a role for B cells and autoantibodies

NIH-funded research University of Mississippi Med Ctr · NIH-11099722

This project looks at whether B cells and a specific antibody linked to preeclampsia cause high blood pressure and problems with brain and kidney function in pregnant people and in their adult children, and whether effects differ by sex.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Mississippi Med Ctr NIH-funded
Lab location1 site (Jackson, United States)
Project IDNIH-11099722 on NIH RePORTER

What this research studies

This work follows people affected by preeclampsia and studies their B cells and an autoantibody called AT1-AA using patient samples alongside laboratory adoptive-transfer models to see how these immune factors influence blood pressure, cognition, and kidney blood flow. Researchers will compare people with and without prior COVID-19 and will examine whether male and female offspring show different long-term blood pressure and brain/kidney outcomes. Some experiments move B cells into model systems to test cause-and-effect and to try blocking the antibody with a peptide to reduce harm. The team aims to connect findings in patients to biological mechanisms that could guide future prevention or treatments.

Who could benefit from this research

Good fit: Ideal candidates are adults with a history of preeclampsia and potentially their adult offspring, especially those receiving care at or near the University of Mississippi Medical Center.

Not a fit: People without a history of preeclampsia, those under 21, or individuals far from the study location are unlikely to be eligible or to receive direct benefit from participation.

Why it matters

Potential benefit: If successful, this work could identify immune-based targets to prevent or treat hypertension and brain or kidney complications after preeclampsia in mothers and reduce long-term risk in their children.

How similar studies have performed: Previous animal studies show AT1-AA can cause hypertension and that blocking it can reduce symptoms, but human evidence and studies on sex differences remain limited.

Where this research is happening

Jackson, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.